Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
03 2019
Historique:
received: 17 11 2017
accepted: 17 12 2018
pubmed: 20 2 2019
medline: 25 4 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

Body-fat distribution is a risk factor for adverse cardiovascular health consequences. We analyzed the association of body-fat distribution, assessed by waist-to-hip ratio adjusted for body mass index, with 228,985 predicted coding and splice site variants available on exome arrays in up to 344,369 individuals from five major ancestries (discovery) and 132,177 European-ancestry individuals (validation). We identified 15 common (minor allele frequency, MAF ≥5%) and nine low-frequency or rare (MAF <5%) coding novel variants. Pathway/gene set enrichment analyses identified lipid particle, adiponectin, abnormal white adipose tissue physiology and bone development and morphology as important contributors to fat distribution, while cross-trait associations highlight cardiometabolic traits. In functional follow-up analyses, specifically in Drosophila RNAi-knockdowns, we observed a significant increase in the total body triglyceride levels for two genes (DNAH10 and PLXND1). We implicate novel genes in fat distribution, stressing the importance of interrogating low-frequency and protein-coding variants.

Identifiants

pubmed: 30778226
doi: 10.1038/s41588-018-0334-2
pii: 10.1038/s41588-018-0334-2
pmc: PMC6560635
mid: NIHMS1016010
doi:

Substances chimiques

Lipids 0
Proteins 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

452-469

Subventions

Organisme : NHLBI NIH HHS
ID : K99 HL130580
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK106621
Pays : United States
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK110113
Pays : United States
Organisme : Medical Research Council
ID : MR/S003746/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9521010
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK056336
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21 HL121422
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_14089
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK093757
Pays : United States
Organisme : British Heart Foundation
ID : FS/12/82/29736
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG007417
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007416
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM126479
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R21 DA040177
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001109
Pays : United States
Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK072193
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL130580
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107786
Pays : United States
Organisme : Medical Research Council
ID : MR/L01341X/1
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK075787
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL119443
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062370
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12015/2
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : R01 HG008983
Pays : United States
Organisme : British Heart Foundation
ID : RG/08/014/24067
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/14/5/30893
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01632X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : K12 HD043483
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : U01 DK062370
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107904
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089256
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD057194
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007055
Pays : United States
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom

Références

Pischon, T. et al. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 359, 2105–2120 (2008).
pubmed: 19005195 doi: 10.1056/NEJMoa0801891
Wang, Y., Rimm, E. B., Stampfer, M. J., Willett, W. C. & Hu, F. B. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am. J. Clin. Nutr. 81, 555–563 (2005).
pubmed: 15755822 doi: 10.1093/ajcn/81.3.555
Canoy, D. Distribution of body fat and risk of coronary heart disease in men and women. Curr. Opin. Cardiol. 23, 591–598 (2008).
pubmed: 18830075 doi: 10.1097/HCO.0b013e328313133a
Snijder, M. B. et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 77, 1192–1197 (2003).
pubmed: 12716671 doi: 10.1093/ajcn/77.5.1192
Yusuf, S. et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005).
pubmed: 16271645 doi: 10.1016/S0140-6736(05)67663-5
Mason, C., Craig, C. L. & Katzmarzyk, P. T. Influence of central and extremity circumferences on all-cause mortality in men and women. Obesity. 16, 2690–2695 (2008).
pubmed: 18927548 doi: 10.1038/oby.2008.438
Karpe, F. & Pinnick, K. E. Biology of upper-body and lower-body adipose tissue—llink to whole-body phenotypes. Nat. Rev. Endocrinol. 11, 90–100 (2015).
pubmed: 25365922 doi: 10.1038/nrendo.2014.185
Manolopoulos, K. N., Karpe, F. & Frayn, K. N. Gluteofemoral body fat as a determinant of metabolic health. Int. J. Obes. 34, 949–959 (2010).
doi: 10.1038/ijo.2009.286
Emdin, C. A. et al. Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA 317, 626–634 (2017).
pubmed: 28196256 pmcid: 5571980 doi: 10.1001/jama.2016.21042
Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015).
pubmed: 25673412 pmcid: 4338562 doi: 10.1038/nature14132
Winkler, T. W. et al. The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet. 11, e1005378 (2015).
pubmed: 26426971 pmcid: 4591371 doi: 10.1371/journal.pgen.1005378
Wen, W. et al. Genome-wide association studies in east asians identify new loci for waist-hip ratio and waist circumference. Sci. Rep. 6, 17958 (2016).
pubmed: 26785701 pmcid: 4726286 doi: 10.1038/srep17958
Gao, C. et al. A comprehensive analysis of common and rare variants to identify adiposity loci in hispanic Americans: the iras family study (IRASFS). PLoS ONE 10, e0134649 (2015).
pubmed: 26599207 pmcid: 4658008 doi: 10.1371/journal.pone.0134649
Graff, M. et al. Genome-wide physical activity interactions in adiposity—meta-analysis of 200,452 adults. PLoS Genet. 13, e1006528 (2017).
pubmed: 28448500 pmcid: 5407576 doi: 10.1371/journal.pgen.1006528
Justice, A. E. et al. Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. Nat. Commun. 8, 14977 (2017).
pubmed: 28443625 pmcid: 5414044 doi: 10.1038/ncomms14977
Ng, M. C. Y. et al. Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. PLoS Genet. 13, e1006719 (2017).
pubmed: 28430825 pmcid: 5419579 doi: 10.1371/journal.pgen.1006719
Aschard, H., Vilhjalmsson, B. J., Joshi, A. D., Price, A. L. & Kraft, P. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am. J. Hum. Genet. 96, 329–339 (2015).
pubmed: 25640676 pmcid: 4320269 doi: 10.1016/j.ajhg.2014.12.021
Day, F. R., Loh, P. R., Scott, R. A., Ong, K. K. & Perry, J. R. A robust example of collider bias in a genetic association study. Am. J. Hum. Genet. 98, 392–393 (2016).
pubmed: 26849114 pmcid: 4746366 doi: 10.1016/j.ajhg.2015.12.019
Feng, S., Liu, D., Zhan, X., Wing, M. K. & Abecasis, G. R. RAREMETAL: fast and powerful meta-analysis for rare variants. Bioinformatics 30, 2828–2829 (2014).
pubmed: 24894501 pmcid: 4173011 doi: 10.1093/bioinformatics/btu367
Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
pubmed: 25597830 doi: 10.1038/ncomms6890
Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017).
pubmed: 28146470 pmcid: 5302847 doi: 10.1038/nature21039
Lamparter, D., Marbach, D., Rueedi, R., Kutalik, Z. & Bergmann, S. Fast and rigorous computation of gene and pathway scores from SNP-based summary statistics. PLoS Comput. Biol. 12, e1004714 (2016).
pubmed: 26808494 pmcid: 4726509 doi: 10.1371/journal.pcbi.1004714
Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015).
pubmed: 25673413 pmcid: 4382211 doi: 10.1038/nature14177
Kawai, M., de Paula, F. J. & Rosen, C. J. New insights into osteoporosis: the bone-fat connection. J. Intern. Med. 272, 317–329 (2012).
pubmed: 22702419 pmcid: 3634716 doi: 10.1111/j.1365-2796.2012.02564.x
Turcot, V. et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat. Genet. 50, 26–41 (2018).
pubmed: 29273807 doi: 10.1038/s41588-017-0011-x
Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758–1766 (2017).
pubmed: 29083408 pmcid: 5709146 doi: 10.1038/ng.3977
Kraja, A. T. et al. New blood pressure-associated loci identified in meta-analyses of 475 000 individuals. Circ. Cardiovasc. Genet. 10, e001778 (2017).
pubmed: 29030403 pmcid: 5776077 doi: 10.1161/CIRCGENETICS.117.001778
Mahajan, A. et al. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet. 11, e1004876 (2015).
pubmed: 25625282 pmcid: 4307976 doi: 10.1371/journal.pgen.1004876
Manning, A. et al. A low-frequency inactivating akt2 variant enriched in the finnish population is associated with fasting insulin levels and type 2 diabetes risk. Diabetes 66, 2019–2032 (2017).
pubmed: 28341696 pmcid: 5482074 doi: 10.2337/db16-1329
Zhao, W. et al. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nat. Genet. 49, 1450–1457 (2017).
pubmed: 28869590 pmcid: 5844224 doi: 10.1038/ng.3943
Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981–990 (2012).
pubmed: 22885922 pmcid: 3442244 doi: 10.1038/ng.2383
Ng, M. C. et al. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet. 10, e1004517 (2014).
pubmed: 25102180 pmcid: 4125087 doi: 10.1371/journal.pgen.1004517
Mahajan, A. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234–244 (2014).
pubmed: 24509480 doi: 10.1038/ng.2897
Saxena, R. et al. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes 62, 1746–1755 (2013).
pubmed: 23300278 pmcid: 3636649 doi: 10.2337/db12-1077
Cook, J. P. & Morris, A. P. Multi-ethnic genome-wide association study identifies novel locus for type 2 diabetes susceptibility. Eur. J. Hum. Genet. 24, 1175–1180 (2016).
pubmed: 27189021 pmcid: 4947384 doi: 10.1038/ejhg.2016.17
Voight, B. F. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579–589 (2010).
pubmed: 20581827 pmcid: 3080658 doi: 10.1038/ng.609
Burdett, T. et al. The NHGRI-EBI Catalog of published genome-wide association studies. V.1.0 edn Vol. 2015 (NHGRI-EBI, 2015).
Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362–9367 (2009).
pubmed: 19474294 doi: 10.1073/pnas.0903103106 pmcid: 2687147
Lutoslawska, G. et al. Relationship between the percentage of body fat and surrogate indices of fatness in male and female Polish active and sedentary students. J. Physiol. Anthropol. 33, 10 (2014).
pubmed: 24887103 pmcid: 4047548 doi: 10.1186/1880-6805-33-10
Verma, M., Rajput, M., Sahoo, S. S., Kaur, N. & Rohilla, R. Correlation between the percentage of body fat and surrogate indices of obesity among adult population in rural block of Haryana. J. Family Med. Prim. Care 5, 154–159 (2016).
pubmed: 27453862 pmcid: 4943124 doi: 10.4103/2249-4863.184642
Pereira, P. F. et al. Measurements of location of body fat distribution: an assessment of colinearity with body mass, adiposity and stature in female adolescents. Rev. Paul. Pediatr. 33, 63–71 (2015).
pubmed: 25623729 pmcid: 4436958 doi: 10.1016/j.rpped.2014.11.011
Lu, Y. et al. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat. Commun. 7, 10495 (2016).
pubmed: 26833246 pmcid: 4740398 doi: 10.1038/ncomms10495
Chambers, J. C. et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 40, 716–718 (2008).
pubmed: 18454146 doi: 10.1038/ng.156
Nead, K. T. et al. Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals. Hum. Mol. Genet. 24, 3582–3594 (2015).
pubmed: 25784503 pmcid: 4498155 doi: 10.1093/hmg/ddv097
Pospisilik, J. A. et al. Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell 140, 148–160 (2010).
pubmed: 20074523 doi: 10.1016/j.cell.2009.12.027
Consortium, G. T. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
doi: 10.1126/science.1262110
Baraille, F., Planchais, J., Dentin, R., Guilmeau, S. & Postic, C. Integration of chrebp-mediated glucose sensing into whole body metabolism. Physiology 30, 428–437 (2015).
pubmed: 26525342 doi: 10.1152/physiol.00016.2015
Kursawe, R. et al. Decreased transcription of ChREBP-alpha/beta isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 62, 837–844 (2013).
pubmed: 23209190 pmcid: 3581226 doi: 10.2337/db12-0889
Lotta, L. A. et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat. Genet. 49, 17–26 (2017).
pubmed: 27841877 doi: 10.1038/ng.3714
Cargill, M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273–290 (2007).
pubmed: 17236132 doi: 10.1086/511051
Hazlett, J. et al. IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun. 13, 282–287 (2012).
doi: 10.1038/gene.2011.80
Karaderi, T. et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology 48, 386–389 (2009).
pubmed: 19189980 doi: 10.1093/rheumatology/ken501
Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
pubmed: 17068223 pmcid: 4410764 doi: 10.1126/science.1135245
Abdollahi, E., Tavasolian, F., Momtazi-Borojeni, A. A., Samadi, M. & Rafatpanah, H. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: comprehensive review. J. Immunotoxicol. 13, 286–300 (2016).
pubmed: 27043356 doi: 10.3109/1547691X.2015.1115448
Abraham, C., Dulai, P. S., Vermeire, S. & Sandborn, W. J. Lessons learned from trials targeting cytokine pathways in patients with inflammatory bowel diseases. Gastroenterology 152, 374–388 e4 (2017).
pubmed: 27780712 doi: 10.1053/j.gastro.2016.10.018
Molinelli, E., Campanati, A., Ganzetti, G. & Offidani, A. Biologic therapy in immune mediated inflammatory disease: basic science and clinical concepts. Curr. Drug Saf. 11, 35–43 (2016).
pubmed: 26463248 doi: 10.2174/1574886310666151014115127
Fuchsberger, C. et al. The genetic architecture of type 2 diabetes. Nature 536, 41–47 (2016).
pubmed: 27398621 pmcid: 5034897 doi: 10.1038/nature18642
Wells, J. C. Sexual dimorphism of body composition. Best. Pract. Res. Clin. Endocrinol. Metab. 21, 415–430 (2007).
pubmed: 17875489 doi: 10.1016/j.beem.2007.04.007
Loomba-Albrecht, L. A. & Styne, D. M. Effect of puberty on body composition. Curr. Opin. Endocrinol. Diabetes. Obes. 16, 10–15 (2009).
pubmed: 19115520 doi: 10.1097/MED.0b013e328320d54c
Rogol, A. D., Roemmich, J. N. & Clark, P. A. Growth at puberty. J. Adolesc. Health 31, 192–200 (2002).
pubmed: 12470915 doi: 10.1016/S1054-139X(02)00485-8
Gibson, G. Rare and common variants: twenty arguments. Nat. Rev. Genet. 13, 135–145 (2012).
pubmed: 22251874 pmcid: 4408201 doi: 10.1038/nrg3118
Stern, J. H., Rutkowski, J. M. & Scherer, P. E. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell. Metab. 23, 770–784 (2016).
pubmed: 27166942 pmcid: 4864949 doi: 10.1016/j.cmet.2016.04.011
Dewey, F. E. et al. Inactivating variants in angptl4 and risk of coronary artery disease. N. Engl. J. Med. 374, 1123–1133 (2016).
pubmed: 26933753 pmcid: 4900689 doi: 10.1056/NEJMoa1510926
Bondestam, J. et al. cDNA cloning, expression studies and chromosome mapping of human type I serine/threonine kinase receptor ALK7 (ACVR1C). Cytogenet. Cell Genet. 95, 157–162 (2001).
pubmed: 12063393 doi: 10.1159/000059339
Jornvall, H., Blokzijl, A., ten Dijke, P. & Ibanez, C. F. The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line. J. Biol. Chem. 276, 5140–5146 (2001).
pubmed: 11084022 doi: 10.1074/jbc.M005200200
Kim, B. C. et al. Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. J. Biol. Chem. 279, 28458–28465 (2004).
pubmed: 15107418 doi: 10.1074/jbc.M313277200
Watanabe, R. et al. The MH1 domains of smad2 and smad3 are involved in the regulation of the ALK7 signals. Biochem. Biophys. Res. Commun. 254, 707–712 (1999).
pubmed: 9920806 doi: 10.1006/bbrc.1998.0118
Kogame, M. et al. ALK7 is a novel marker for adipocyte differentiation. J. Med. Invest. 53, 238–245 (2006).
pubmed: 16953060 doi: 10.2152/jmi.53.238
Murakami, M. et al. Expression of activin receptor-like kinase 7 in adipose tissues. Biochem. Genet. 51, 202–210 (2013).
pubmed: 23264230 doi: 10.1007/s10528-012-9555-8
Carlsson, L. M. et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem. Biophys. Res. Commun. 382, 309–314 (2009).
pubmed: 19275893 pmcid: 2681012 doi: 10.1016/j.bbrc.2009.03.014
Carithers, L. J. & Moore, H. M. The genotype-tissue expression (GTEx) project. Biopreserv. Biobank. 13, 307–308 (2015).
pubmed: 26484569 pmcid: 4692118 doi: 10.1089/bio.2015.29031.hmm
Yogosawa, S., Mizutani, S., Ogawa, Y. & Izumi, T. Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor gamma and C/EBPalpha. Diabetes 62, 115–123 (2013).
pubmed: 22933117 doi: 10.2337/db12-0295
Yogosawa, S. & Izumi, T. Roles of activin receptor-like kinase 7 signaling and its target, peroxisome proliferator-activated receptor gamma, in lean and obese adipocytes. Adipocyte 2, 246–250 (2013).
pubmed: 24052900 pmcid: 3774700 doi: 10.4161/adip.24974
Seifi, M., Ghasemi, A., Namipashaki, A. & Samadikuchaksaraei, A. Is C771G polymorphism of MLX interacting protein-like (MLXIPL) gene a novel genetic risk factor for non-alcoholic fatty liver disease? Cell Mol. Biol. 60, 37–42 (2014).
pubmed: 26177557
Cairo, S., Merla, G., Urbinati, F., Ballabio, A. & Reymond, A. WBSCR14, a gene mapping to the Williams–Beuren syndrome deleted region, is a new member of the Mlx transcription factor network. Hum. Mol. Genet. 10, 617–627 (2001).
pubmed: 11230181 doi: 10.1093/hmg/10.6.617
Ambele, M. A., Dessels, C., Durandt, C. & Pepper, M. S. Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation. Stem Cell Res. 16, 725–734 (2016).
pubmed: 27108396 doi: 10.1016/j.scr.2016.04.011
Marchler-Bauer, A. et al. CDD: NCBI’s conserved domain database. Nucleic Acids Res. 43, D222–D226 (2015).
doi: 10.1093/nar/gku1221 pubmed: 25414356
Toyofuku, T. et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J. 26, 1373–1384 (2007).
pubmed: 17318185 pmcid: 1817636 doi: 10.1038/sj.emboj.7601589
Gitler, A. D., Lu, M. M. & Epstein, J. A. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev. Cell. 7, 107–116 (2004).
pubmed: 15239958 doi: 10.1016/j.devcel.2004.06.002
Luchino, J. et al. Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers. Cancer Cell. 24, 673–685 (2013).
pubmed: 24139859 doi: 10.1016/j.ccr.2013.09.010
Shimizu, I. et al. Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity. Cell. Metab. 18, 491–504 (2013).
pubmed: 24093674 doi: 10.1016/j.cmet.2013.09.001
Verzijl, H. T., van der Zwaag, B., Cruysberg, J. R. & Padberg, G. W. Mobius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology 61, 327–333 (2003).
pubmed: 12913192 doi: 10.1212/01.WNL.0000076484.91275.CD
Verzijl, H. T., van der Zwaag, B., Lammens, M., ten Donkelaar, H. J. & Padberg, G. W. The neuropathology of hereditary congenital facial palsy vs Mobius syndrome. Neurology 64, 649–653 (2005).
pubmed: 15728286 doi: 10.1212/01.WNL.0000151848.65094.55
Fujita, M., Reinhart, F. & Neutra, M. Convergence of apical and basolateral endocytic pathways at apical late endosomes in absorptive cells of suckling rat ileum in vivo. J. Cell Sci. 97(Pt 2), 385–394 (1990).
pubmed: 2277098 doi: 10.1242/jcs.97.2.385
Briegel, W. Neuropsychiatric findings of mobius sequence—a review. Clin. Genet. 70, 91–97 (2006).
pubmed: 16879188 doi: 10.1111/j.1399-0004.2006.00649.x
Ta-Shma, A. et al. Isolated truncus arteriosus associated with a mutation in the plexin-D1 gene. Am. J. Med. Genet. A. 161A, 3115–3120 (2013).
pubmed: 24254849 doi: 10.1002/ajmg.a.36194
Mazzotta, C. et al. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis. Arthritis Res. Ther. 17, 221 (2015).
pubmed: 26292963 pmcid: 4546224 doi: 10.1186/s13075-015-0749-4
Yang, W. J. et al. Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Mol. Med. 7, 1267–1284 (2015).
pubmed: 26194913 pmcid: 4604683 doi: 10.15252/emmm.201404922
Zygmunt, T. et al. Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1. Dev. Cell. 21, 301–314 (2011).
pubmed: 21802375 pmcid: 3156278 doi: 10.1016/j.devcel.2011.06.033
Kim, J., Oh, W. J., Gaiano, N., Yoshida, Y. & Gu, C. Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism. Genes Dev. 25, 1399–1411 (2011).
pubmed: 21724832 pmcid: 3134083 doi: 10.1101/gad.2042011
Bertolino, P. et al. Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc. Natl Acad. Sci. USA 105, 7246–7251 (2008).
pubmed: 18480258 doi: 10.1073/pnas.0801285105 pmcid: 2438235
Haworth, K. E. et al. Methylation of the FGFR2 gene is associated with high birth weight centile in humans. Epigenomics 6, 477–491 (2014).
pubmed: 25431941 doi: 10.2217/epi.14.40
Chi, X. et al. Angiopoietin-like 4 modifies the interactions between lipoprotein lipase and its endothelial cell transporter GPIHBP1. J. Biol. Chem. 290, 11865–11877 (2015).
pubmed: 25809481 pmcid: 4424327 doi: 10.1074/jbc.M114.623769
Catoire, M. et al. Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise. Proc. Natl Acad. Sci. USA 111, E1043–E1052 (2014).
pubmed: 24591600 doi: 10.1073/pnas.1400889111 pmcid: 3964070
van Raalte, D. H. et al. Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans. Exp. Clin. Endocrinol. Diabetes. 120, 598–603 (2012).
pubmed: 22972030 doi: 10.1055/s-0032-1321864
Koster, A. et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146, 4943–4950 (2005).
pubmed: 16081640 doi: 10.1210/en.2005-0476
Thiagalingam, A. et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol. Cell. Biol. 16, 5335–5345 (1996).
pubmed: 8816445 pmcid: 231532 doi: 10.1128/MCB.16.10.5335
Bonomo, J. A. et al. The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease. Hum. Mol. Genet. 23, 6441–6447 (2014).
pubmed: 25027322 pmcid: 4240197 doi: 10.1093/hmg/ddu362
Thiagalingam, A., Lengauer, C., Baylin, S. B. & Nelkin, B. D. RREB1, a ras responsive element binding protein, maps to human chromosome 6p25. Genomics 45, 630–632 (1997).
pubmed: 9367691 doi: 10.1006/geno.1997.5001
Bisogno, T. et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463–468 (2003).
pubmed: 14610053 pmcid: 2173631 doi: 10.1083/jcb.200305129
Global Lipids Genetics, C. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
doi: 10.1038/ng.2797
Kooner, J. S. et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet. 40, 149–151 (2008).
pubmed: 18193046 doi: 10.1038/ng.2007.61
Pan, L. A. et al. G771C polymorphism in the mlxipl gene is associated with a risk of coronary artery disease in the chinese: a case-control study. Cardiology 114, 174–178 (2009).
pubmed: 19571538 doi: 10.1159/000226610
Kang, G., Leech, C. A., Chepurny, O. G., Coetzee, W. A. & Holz, G. G. Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells. J. Physiol. 586, 1307–1319 (2008).
pubmed: 18202100 pmcid: 2375670 doi: 10.1113/jphysiol.2007.143818
Ji, Z., Mei, F. C. & Cheng, X. Epac, not PKA catalytic subunit, is required for 3T3-L1 preadipocyte differentiation. Front Biosci. 2, 392–398 (2010).
doi: 10.2741/e99
Martini, C. N., Plaza, M. V. & Vila Mdel, C. PKA-dependent and independent cAMP signaling in 3T3-L1 fibroblasts differentiation. Mol. Cell. Endocrinol. 298, 42–47 (2009).
pubmed: 19010385 doi: 10.1016/j.mce.2008.10.023
Petersen, R. K. et al. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol. Cell. Biol. 28, 3804–3816 (2008).
pubmed: 18391018 pmcid: 2423297 doi: 10.1128/MCB.00709-07
Yan, J. et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol. Cell. Biol. 33, 918–926 (2013).
pubmed: 23263987 pmcid: 3623083 doi: 10.1128/MCB.01227-12
Gesta, S. et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl Acad. Sci. USA 103, 6676–6681 (2006).
pubmed: 16617105 doi: 10.1073/pnas.0601752103 pmcid: 1458940
Gesta, S. et al. Mesodermal developmental gene Tbx15 impairs adipocyte differentiation and mitochondrial respiration. Proc. Natl Acad. Sci. USA 108, 2771–2776 (2011).
pubmed: 21282637 doi: 10.1073/pnas.1019704108 pmcid: 3041070
Lee, K. Y. et al. Tbx15 controls skeletal muscle fibre-type determination and muscle metabolism. Nat. Commun. 6, 8054 (2015).
pubmed: 26299309 doi: 10.1038/ncomms9054
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379 pmcid: 4380465 doi: 10.1371/journal.pmed.1001779
Liu, D. J. et al. Meta-analysis of gene-level tests for rare variant association. Nat. Genet. 46, 200–204 (2014).
pubmed: 24336170 doi: 10.1038/ng.2852
Goldstein, J. I. et al. zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinformatics 28, 2543–2545 (2012).
pubmed: 22843986 pmcid: 3463112 doi: 10.1093/bioinformatics/bts479
Winkler, T. W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192–1212 (2014).
pubmed: 24762786 pmcid: 4083217 doi: 10.1038/nprot.2014.071
Winkler, T. W. et al. EasyStrata: evaluation and visualization of stratified genome-wide association meta-analysis data. Bioinformatics 31, 259–261 (2015).
pubmed: 25260699 doi: 10.1093/bioinformatics/btu621
Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014).
pubmed: 24463508 pmcid: 4136494 doi: 10.1038/nature12975
Yang, J. et al. Genomic inflation factors under polygenic inheritance. Eur. J. Hum. Genet. 19, 807–812 (2011).
pubmed: 21407268 pmcid: 3137506 doi: 10.1038/ejhg.2011.39
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, S1–S3 (2012).
doi: 10.1038/ng.1057
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
pubmed: 17572673 doi: 10.1038/ng2088
Wellcome Trust Case Control, C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
doi: 10.1038/nature05911
Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499–511 (2010).
doi: 10.1038/nrg2796 pubmed: 20517342
Frey, B. J. & Dueck, D. Clustering by passing messages between data points. Science 315, 972–976 (2007).
doi: 10.1126/science.1136800 pubmed: 17218491
Moayyeri, A., Hammond, C. J., Valdes, A. M. & Spector, T. D. Cohort profile: TwinsUK and healthy ageing twin study. Int. J. Epidemiol. 42, 76–85 (2013).
pubmed: 22253318 doi: 10.1093/ije/dyr207
Boyd, A. et al. Cohort profile: the ‘children of the 90s’–the index offspring of the Avon Longitudinal Study of parents and children. Int. J. Epidemiol. 42, 111–127 (2013).
pubmed: 22507743 doi: 10.1093/ije/dys064
Kutalik, Z., Whittaker, J., Waterworth, D., Beckmann, J. S. & Bergmann, S. Novel method to estimate the phenotypic variation explained by genome-wide association studies reveals large fraction of the missing heritability. Genet. Epidemiol. 35, 341–349 (2011).
pubmed: 21465548 doi: 10.1002/gepi.20582
Billingsley, P. Probability and Measure (Wiley, New York, 1986).
Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151–1161 (2016).
pubmed: 27618447 pmcid: 5056636 doi: 10.1038/ng.3654
Nikpay, M. et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121–1130 (2015).
pubmed: 26343387 pmcid: 4589895 doi: 10.1038/ng.3396
Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).
pubmed: 12883005 pmcid: 170937 doi: 10.1073/pnas.1530509100
Civelek, M. et al. Genetic regulation of adipose gene expression and cardio-metabolic traits. Am. J. Hum. Genet. 100, 428–443 (2017).
pubmed: 28257690 pmcid: 5339333 doi: 10.1016/j.ajhg.2017.01.027

Auteurs

Anne E Justice (AE)

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Weis Center for Research, Geisinger Health System, Danville, PA, USA.

Tugce Karaderi (T)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University, Famagusta, Cyprus.

Heather M Highland (HM)

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Kristin L Young (KL)

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.

Mariaelisa Graff (M)

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.

Yingchang Lu (Y)

Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Valérie Turcot (V)

Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.

Paul L Auer (PL)

Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.

Rebecca S Fine (RS)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.
Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.

Xiuqing Guo (X)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Claudia Schurmann (C)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Adelheid Lempradl (A)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Eirini Marouli (E)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Anubha Mahajan (A)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.

Thomas W Winkler (TW)

Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.

Adam E Locke (AE)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, USA.

Carolina Medina-Gomez (C)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Tõnu Esko (T)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.
Estonian Genome Center, University of Tartu, Tartu, Estonia.

Sailaja Vedantam (S)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.
Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.

Ayush Giri (A)

Department of Obstetrics and Gynecology, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.

Ken Sin Lo (KS)

Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.
Department of Obstetrics and Gynecology, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.

Tamuno Alfred (T)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Poorva Mudgal (P)

Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Maggie C Y Ng (MCY)

Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Nancy L Heard-Costa (NL)

Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
NHLBI Framingham Heart Study, Framingham, MA, USA.

Mary F Feitosa (MF)

Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.

Alisa K Manning (AK)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard University Medical School, Boston, MA, USA.
Massachusetts General Hospital, Boston, MA, USA.

Sara M Willems (SM)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Suthesh Sivapalaratnam (S)

Massachusetts General Hospital, Boston, MA, USA.
Department of Vascular Medicine, AMC, Amsterdam, The Netherlands.
Department of Haematology, University of Cambridge, Cambridge, UK.

Goncalo Abecasis (G)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Dewan S Alam (DS)

School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Canada.

Matthew Allison (M)

Department of Family Medicine & Public Health, University of California, San Diego, La Jolla, CA, USA.

Philippe Amouyel (P)

INSERM U1167, Lille, France.
Institut Pasteur de Lille, U1167, Lille, France.
U1167-RID-AGE, Universite de Lille - Risk factors and molecular determinants of aging-related diseases, Lille, France.

Zorayr Arzumanyan (Z)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Beverley Balkau (B)

INSERM U1018, Centre de recherche en Épidemiologie et Sante des Populations (CESP), Villejuif, France.

Lisa Bastarache (L)

Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.

Sven Bergmann (S)

Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Lawrence F Bielak (LF)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Matthias Blüher (M)

IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.
Department of Medicine, University of Leipzig, Leipzig, Germany.

Michael Boehnke (M)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.

Eric Boerwinkle (E)

Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.

Carsten A Böger (CA)

Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.

Jette Bork-Jensen (J)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Erwin P Bottinger (EP)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Donald W Bowden (DW)

Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Ivan Brandslund (I)

Department of Clinical Biochemistry, Lillebaelt Hospital, Vejle, Denmark.
Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Linda Broer (L)

Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Amber A Burt (AA)

Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.

Adam S Butterworth (AS)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Mark J Caulfield (MJ)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
NIHR Barts Cardiovascular Research Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.

Giancarlo Cesana (G)

Research Centre on Public Health, University of Milano-Bicocca, Monza, Italy.

John C Chambers (JC)

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Department of Cardiology, London North West Healthcare NHS Trust, Ealing Hospital, Middlesex, UK.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, London, UK.
MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.

Daniel I Chasman (DI)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Division of Preventive Medicine, Brigham and Women's and Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Yii-Der Ida Chen (YI)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Rajiv Chowdhury (R)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Cramer Christensen (C)

Medical department, Lillebaelt Hospital, Vejle, Denmark.

Audrey Y Chu (AY)

Division of Preventive Medicine, Brigham and Women's and Harvard Medical School, Boston, MA, USA.

Francis S Collins (FS)

Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

James P Cook (JP)

Department of Biostatistics, University of Liverpool, Liverpool, UK.

Amanda J Cox (AJ)

Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.

David S Crosslin (DS)

Department of Biomedical Infomatics and Medical Education, University of Washington, Seattle, WA, USA.

John Danesh (J)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wellcome Trust Sanger Institute, Hinxton, UK.
British Heart Foundation Cambridge Centre of Excellence, Department of Medicine, University of Cambridge, Cambridge, UK.

Paul I W de Bakker (PIW)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Simon de Denus (S)

Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.
Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec, Canada.

Renée de Mutsert (R)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

George Dedoussis (G)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.

Ellen W Demerath (EW)

Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.

Joe G Dennis (JG)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Josh C Denny (JC)

Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.

Emanuele Di Angelantonio (E)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
British Heart Foundation Cambridge Centre of Excellence, Department of Medicine, University of Cambridge, Cambridge, UK.

Marcus Dörr (M)

Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.

Fotios Drenos (F)

Institute of Cardiovascular Science, University College London, London, UK.
MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Department of Life Sciences, Brunel University London, Uxbridge, UK.

Marie-Pierre Dubé (MP)

Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.
Department of Medicine, Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada.

Alison M Dunning (AM)

Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Douglas F Easton (DF)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Paul Elliott (P)

Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Evangelos Evangelou (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.

Aliki-Eleni Farmaki (AE)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.

Shuang Feng (S)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

Ele Ferrannini (E)

CNR Institute of Clinical Physiology, Pisa, Italy.
Department of Clinical & Experimental Medicine, University of Pisa, Pisa, Italy.

Jean Ferrieres (J)

Toulouse University School of Medicine, Toulouse, France.

Jose C Florez (JC)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard University Medical School, Boston, MA, USA.
Massachusetts General Hospital, Boston, MA, USA.

Myriam Fornage (M)

Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Caroline S Fox (CS)

NHLBI Framingham Heart Study, Framingham, MA, USA.

Paul W Franks (PW)

Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmo, Sweden.
Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
Department of Public Health and Clinical Medicine, Unit of Medicine, Umeå University, Umeå, Sweden.

Nele Friedrich (N)

Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.

Wei Gan (W)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.

Ilaria Gandin (I)

Ilaria Gandin, Research Unit, AREA Science Park, Trieste, Italy.

Paolo Gasparini (P)

Department of Medical Sciences, University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy.

Vilmantas Giedraitis (V)

Geriatrics, Department of Public Health, Uppsala University, Uppsala, Sweden.

Giorgia Girotto (G)

Department of Medical Sciences, University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy.

Mathias Gorski (M)

Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.

Harald Grallert (H)

German Center for Diabetes Research, München-Neuherberg, Germany.
Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Research Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.

Niels Grarup (N)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Megan L Grove (ML)

Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Stefan Gustafsson (S)

Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Jeff Haessler (J)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle WA, USA.

Torben Hansen (T)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Andrew T Hattersley (AT)

University of Exeter Medical School, University of Exeter, Exeter, UK.

Caroline Hayward (C)

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Iris M Heid (IM)

Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.

Oddgeir L Holmen (OL)

K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

G Kees Hovingh (GK)

Department of Vascular Medicine, AMC, Amsterdam, The Netherlands.

Joanna M M Howson (JMM)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Yao Hu (Y)

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Yi-Jen Hung (YJ)

Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital Songshan Branch, Taipei, Taiwan.
School of Medicine, National Defense Medical Center, Taipei, Taiwan.

Kristian Hveem (K)

K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
HUNT Research Center, Department of Public Health, Norwegian University of Science and Technology, Levanger, Norway.

M Arfan Ikram (MA)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Erik Ingelsson (E)

Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA.

Anne U Jackson (AU)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

Gail P Jarvik (GP)

Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.
Department of Genome Sciences, University of Washington, Seattle, WA, USA.

Yucheng Jia (Y)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Torben Jørgensen (T)

Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Research Center for Prevention and Health, Capital Region of Denmark, Glostrup, Denmark.

Pekka Jousilahti (P)

National Institute for Health and Welfare, Helsinki, Finland.

Johanne M Justesen (JM)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Bratati Kahali (B)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA.
Centre for Brain Research, Indian Institute of Science, Bangalore, India.

Maria Karaleftheri (M)

Echinos Medical Centre, Echinos, Greece.

Sharon L R Kardia (SLR)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Fredrik Karpe (F)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.

Frank Kee (F)

UKCRC Centre of Excellence for Public Health Research, Queens University Belfast, Belfast, UK.

Hidetoshi Kitajima (H)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.

Pirjo Komulainen (P)

Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.

Jaspal S Kooner (JS)

Department of Cardiology, London North West Healthcare NHS Trust, Ealing Hospital, Middlesex, UK.
Imperial College Healthcare NHS Trust, London, UK.
MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.
National Heart and Lung Institute, Imperial College London, Hammersmith Hospital Campus, London, UK.

Peter Kovacs (P)

IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.

Bernhard K Krämer (BK)

University Medical Centre Mannheim, 5th Medical Department, University of Heidelberg, Mannheim, Germany.

Kari Kuulasmaa (K)

National Institute for Health and Welfare, Helsinki, Finland.

Johanna Kuusisto (J)

Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Markku Laakso (M)

Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Timo A Lakka (TA)

Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio Campus, Finland.
Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.

David Lamparter (D)

Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Verge Genomics, San Fransico, CA, USA.

Leslie A Lange (LA)

Division of Biomedical and Personalized Medicine, Department of Medicine, University of Colorado-Denver, Aurora, CO, USA.

Claudia Langenberg (C)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Eric B Larson (EB)

Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.
Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Department of Health Services, University of Washington, Seattle, WA, USA.

Nanette R Lee (NR)

Department of Anthropology, Sociology, and History, University of San Carlos, Cebu City, Philippines.
USC-Office of Population Studies Foundation, Inc., University of San Carlos, Cebu City, Philippines.

Wen-Jane Lee (WJ)

Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Department of Social Work, Tunghai University, Taichung, Taiwan.

Terho Lehtimäki (T)

Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
Department of Clinical Chemistry, Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.

Cora E Lewis (CE)

Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Huaixing Li (H)

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Jin Li (J)

Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.

Ruifang Li-Gao (R)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

Li-An Lin (LA)

Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Xu Lin (X)

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Lars Lind (L)

Uppsala University, Uppsala, Sweden.

Jaana Lindström (J)

National Institute for Health and Welfare, Helsinki, Finland.

Allan Linneberg (A)

Research Center for Prevention and Health, Capital Region of Denmark, Glostrup, Denmark.
Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Ching-Ti Liu (CT)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Dajiang J Liu (DJ)

Department of Public Health Sciences, Institute for Personalized Medicine, The Pennsylvania State University College of Medicine, Hershey, PA, USA.

Jian'an Luan (J)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Leo-Pekka Lyytikäinen (LP)

Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
Department of Clinical Chemistry, Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.

Stuart MacGregor (S)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Reedik Mägi (R)

Estonian Genome Center, University of Tartu, Tartu, Estonia.

Satu Männistö (S)

National Institute for Health and Welfare, Helsinki, Finland.

Gaëlle Marenne (G)

Wellcome Trust Sanger Institute, Hinxton, UK.

Jonathan Marten (J)

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Nicholas G D Masca (NGD)

Department of Cardiovascular Sciences, Univeristy of Leicester, Glenfield Hospital, Leicester, UK.
NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.

Mark I McCarthy (MI)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.

Karina Meidtner (K)

German Center for Diabetes Research, München-Neuherberg, Germany.
Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.

Evelin Mihailov (E)

Estonian Genome Center, University of Tartu, Tartu, Estonia.

Leena Moilanen (L)

Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

Marie Moitry (M)

Department of Epidemiology and Public Health, University of Strasbourg, Strasbourg, France.
Department of Public Health, University Hospital of Strasbourg, Strasbourg, France.

Dennis O Mook-Kanamori (DO)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.

Anna Morgan (A)

Department of Medical Sciences, University of Trieste, Trieste, Italy.

Andrew P Morris (AP)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Department of Biostatistics, University of Liverpool, Liverpool, UK.

Martina Müller-Nurasyid (M)

Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-Universitat, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Patricia B Munroe (PB)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
NIHR Barts Cardiovascular Research Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.

Narisu Narisu (N)

Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Christopher P Nelson (CP)

Department of Cardiovascular Sciences, Univeristy of Leicester, Glenfield Hospital, Leicester, UK.
NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.

Matt Neville (M)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.

Ioanna Ntalla (I)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Jeffrey R O'Connell (JR)

Program for Personalized and Genomic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Katharine R Owen (KR)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.

Oluf Pedersen (O)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Gina M Peloso (GM)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Craig E Pennell (CE)

Division of Obstetric and Gynaecology, School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
School of Medicine and Public Health, Faculty of Medicine and Health, The University of Newcastle, Newcastle, New South Wales, Australia.

Markus Perola (M)

National Institute for Health and Welfare, Helsinki, Finland.
Institute for Molecular Medicine (FIMM) and Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland.

James A Perry (JA)

Program for Personalized and Genomic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

John R B Perry (JRB)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Tune H Pers (TH)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Ailith Ewing (A)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Ozren Polasek (O)

School of Medicine, University of Split, Split, Croatia.
Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Olli T Raitakari (OT)

Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.

Asif Rasheed (A)

Centre for Non-Communicable Diseases, Karachi, Pakistan.

Chelsea K Raulerson (CK)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Rainer Rauramaa (R)

Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio Campus, Finland.

Dermot F Reilly (DF)

Genetics and Pharmacogenomics, Merck & Co., Inc., Boston, MA, USA.

Alex P Reiner (AP)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle WA, USA.
Department of Epidemiology, University of Washington, Seattle, WA, USA.

Paul M Ridker (PM)

Division of Preventive Medicine, Brigham and Women's and Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Manuel A Rivas (MA)

Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.

Neil R Robertson (NR)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Antonietta Robino (A)

Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.

Igor Rudan (I)

Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Katherine S Ruth (KS)

Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK.

Danish Saleheen (D)

Centre for Non-Communicable Diseases, Karachi, Pakistan.
Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Veikko Salomaa (V)

National Institute for Health and Welfare, Helsinki, Finland.

Nilesh J Samani (NJ)

Department of Cardiovascular Sciences, Univeristy of Leicester, Glenfield Hospital, Leicester, UK.
NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.

Pamela J Schreiner (PJ)

Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN, USA.

Matthias B Schulze (MB)

German Center for Diabetes Research, München-Neuherberg, Germany.
Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.

Robert A Scott (RA)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Marcelo Segura-Lepe (M)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Xueling Sim (X)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, Singapore, Singapore.

Andrew J Slater (AJ)

Genetics, Target Sciences, GlaxoSmithKline, Research Triangle Park, NC, USA.
OmicSoft a QIAGEN Company, Cary, NC, USA.

Kerrin S Small (KS)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

Blair H Smith (BH)

Division of Population Health Sciences, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Generation Scotland, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.

Jennifer A Smith (JA)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Lorraine Southam (L)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Wellcome Trust Sanger Institute, Hinxton, UK.

Timothy D Spector (TD)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

Elizabeth K Speliotes (EK)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA.

Kari Stefansson (K)

deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Valgerdur Steinthorsdottir (V)

deCODE Genetics/Amgen Inc., Reykjavik, Iceland.

Kathleen E Stirrups (KE)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

Konstantin Strauch (K)

Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, Germany.

Heather M Stringham (HM)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

Michael Stumvoll (M)

IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.
Department of Medicine, University of Leipzig, Leipzig, Germany.

Liang Sun (L)

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Praveen Surendran (P)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Karin M A Swart (KMA)

Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.

Jean-Claude Tardif (JC)

Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.
Department of Medicine, Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada.

Kent D Taylor (KD)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Alexander Teumer (A)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Deborah J Thompson (DJ)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Gudmar Thorleifsson (G)

deCODE Genetics/Amgen Inc., Reykjavik, Iceland.

Unnur Thorsteinsdottir (U)

deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Betina H Thuesen (BH)

Research Center for Prevention and Health, Capital Region of Denmark, Glostrup, Denmark.

Anke Tönjes (A)

Center for Pediatric Research, Department for Women's and Child Health, University of Leipzig, Leipzig, Germany.

Mina Torres (M)

USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.

Emmanouil Tsafantakis (E)

Anogia Medical Centre, Anogia, Greece.

Jaakko Tuomilehto (J)

National Institute for Health and Welfare, Helsinki, Finland.
Centre for Vascular Prevention, Danube-University Krems, Krems, Austria.
Dasman Diabetes Institute, Dasman, Kuwait.
Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.

André G Uitterlinden (AG)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Matti Uusitupa (M)

Department of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Cornelia M van Duijn (CM)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Mauno Vanhala (M)

Central Finland Central Hospital, Jyvaskyla, Finland.
University of Eastern Finland, Kuopio, Finland.

Rohit Varma (R)

USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.

Sita H Vermeulen (SH)

Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Henrik Vestergaard (H)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Veronique Vitart (V)

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Thomas F Vogt (TF)

Cardiometabolic Disease, Merck & Co., Inc., Kenilworth, NJ, USA.

Dragana Vuckovic (D)

Department of Medical Sciences, University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy.

Lynne E Wagenknecht (LE)

Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Mark Walker (M)

Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle, UK.

Lars Wallentin (L)

Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Feijie Wang (F)

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Carol A Wang (CA)

Division of Obstetric and Gynaecology, School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
School of Medicine and Public Health, Faculty of Medicine and Health, The University of Newcastle, Newcastle, New South Wales, Australia.

Shuai Wang (S)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Helen R Warren (HR)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
NIHR Barts Cardiovascular Research Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.

Dawn M Waterworth (DM)

Genetics, Target Sciences, GlaxoSmithKline, Collegeville, PA, USA.

Jennifer Wessel (J)

Departments of Epidemiology & Medicine, Diabetes Translational Research Center, Fairbanks School of Public Health & School of Medicine, Indiana University, Indiana, IN, USA.

Harvey D White (HD)

Green Lane Cardiovascular Service, Auckland City Hospital and University of Auckland, Auckland, New Zealand.

Cristen J Willer (CJ)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.

James G Wilson (JG)

Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA.

Andrew R Wood (AR)

Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK.

Ying Wu (Y)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Hanieh Yaghootkar (H)

Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK.

Jie Yao (J)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Laura M Yerges-Armstrong (LM)

Program for Personalized and Genomic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
GlaxoSmithKline, King of Prussia, PA, USA.

Robin Young (R)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
University of Glasgow, Glasgow, UK.

Eleftheria Zeggini (E)

Wellcome Trust Sanger Institute, Hinxton, UK.

Xiaowei Zhan (X)

Department of Clinical Sciences, Quantitative Biomedical Research Center, Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Weihua Zhang (W)

Department of Cardiology, London North West Healthcare NHS Trust, Ealing Hospital, Middlesex, UK.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Jing Hua Zhao (JH)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Wei Zhao (W)

Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

He Zheng (H)

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Wei Zhou (W)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

M Carola Zillikens (MC)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Fernando Rivadeneira (F)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Ingrid B Borecki (IB)

Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.

J Andrew Pospisilik (JA)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Panos Deloukas (P)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD), King Abdulaziz University, Jeddah, Saudi Arabia.

Timothy M Frayling (TM)

Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK.

Guillaume Lettre (G)

Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.
Department of Medicine, Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada.

Karen L Mohlke (KL)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Jerome I Rotter (JI)

Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.

Zoltán Kutalik (Z)

Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Joel N Hirschhorn (JN)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.
Departments of Pediatrics and Genetics, Harvard Medical School, Boston, MA, USA.

L Adrienne Cupples (LA)

NHLBI Framingham Heart Study, Framingham, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Ruth J F Loos (RJF)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Kari E North (KE)

Department of Epidemiology and Carolina Center of Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. kari_north@unc.edu.

Cecilia M Lindgren (CM)

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. celi@well.ox.ac.uk.
Li Ka Shing Centre for Health Information and Discovery, The Big Data Institute, University of Oxford, Oxford, UK. celi@well.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH